A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
SARASOTA, Fla., April 12, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System,...
Company to Host Conference Call on March 30 at 4:30pm ET (Details Below)SARASOTA, Fla., March 30, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers...
SARASOTA, Fla., March 29, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., March 26, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture...
INVO has partnered with experienced reproductive specialists who are strong advocates of the INVOcell solutionClinic to be located in Birmingham, Alabama with a focus on providing INVOcell as an efficient, effective and affordable fertility treatment option for the...
SARASOTA, Fla., March 11, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
SARASOTA, Fla., March 8, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
SARASOTA, Fla., March 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
- Spain marks INVO's initial entry into the European market- Europe represents approximately 30% of the multi-billion dollar global fertility marketplace- The first three clinics in Spain have placed initial orders for INVOcell - an effective and affordable...
- Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...